$TLRY TILRAY ON WATCH FOR SIGNS OF RECOVERY

The cannabis bubble from last year, well and truly burst for TLRY having ran to a post IPO price of $300 it reached a low of $34 within 1 year. The majority of cannabis stocks are in a bear market, as sentiment has turned very negative on the sector. This week TLRY has shown some signs of recovery but the stock is under pressure from all the MA'S and a long term trendline above. Having produced a few green candles with decent volume and the announcement of a new deal with NEPT it could possibly add some stimulus to the stock. Rumor and speculation is never far away from TLRY which may have also helped friday's price action.


ANALYSTS AVERAGE PRICE TARGET $78
AVERAGE ANALYSTS RECOMMENDATION OVERWEIGHT
SHORT INTEREST 30%

COMPANY PROFILE
Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. Its products include dried cannabis and cannabis extracts. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.